Press Release


Positive Partial 12-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study
Oct 22, 2024 21:20 JST
Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it has received partial 12-week (final) body weight results from the recently completed animal study WEIGHT-A24-1 (the "Study").
More info..

Latest Release


More Latest Release >>